Lifang Lin

1.5k citations
45 papers · 1.2k indexed · h-index 17
Topics
MicroRNA in disease regulation (6 papers)Autophagy in Disease and Therapy (4 papers)Genetics, Aging, and Longevity in Model Organisms (3 papers)

In The Last Decade

Lifang Lin

45 papers receiving 1.2k citations

Peers

Lifang Lin
Comparison fields: 5 of 97
  • Cellular and Molecular Neuroscience 508
  • Molecular Biology 476
  • Developmental Neuroscience 306
  • Cancer Research 147
  • Surgery 121
Replace Hiroyuki Koizumi with:
Hiroyuki Koizumi Japan
Ryan Insolera United States
Jason M. Newbern United States
Marie‐Christine Birling France
Avtar Roopra United States
Yongcheol Cho South Korea
Ivy S. Samuels United States
John K. Chilton United Kingdom
Carolanne E. Milligan United States
PS DiStefano United States
Lifang Lin relative to Hiroyuki Koizumi Japan Hiroyuki Koizumi's profile →
Citations per field
00.5×1.5×
Hiroyuki Koizumi · 1×
Citations per year

Countries citing papers authored by Lifang Lin

Since Specialization
Citations

This map shows the geographic impact of Lifang Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lifang Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lifang Lin more than expected).

Fields of papers citing papers by Lifang Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lifang Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lifang Lin. The network helps show where Lifang Lin may publish in the future.

Co-authorship network of co-authors of Lifang Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Lifang Lin. A scholar is included among the top collaborators of Lifang Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lifang Lin. Lifang Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 5
2 7
3 6
4 7
5 18
6 46
7 5
8 7
9 28
10 23
11 11
12 39
13 1
14 47
15 11
16 10
17 14
18 2
19 218
20 51

About Lifang Lin

Lifang Lin is a scholar working on Aging, Biological Psychiatry and Cancer Research, having authored 45 papers that have together received 1.2k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (6 papers), Autophagy in Disease and Therapy (4 papers) and Genetics, Aging, and Longevity in Model Organisms (3 papers). The work is most often cited by research in Developmental Neuroscience (306 citations), Cellular and Molecular Neuroscience (508 citations) and Aging (47 citations). Lifang Lin has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Lei Mao, Wei Wu, Lucien J. Houenou, Ling Li, Linus Olson, Johan Widenfalk, Barry J. Hoffer, Takahiro Kohno, Ted Ebendal and Wang Xuemin. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026